Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
Go back to Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers| (NASDAQ: GNPX) | Delayed: 4.48 +0.16 (3.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.32 | 52 Week High | $ | |||
| Open | $4.20 | 52 Week Low | $ | |||
| Day High | $4.89 | P/E | N/A | |||
| Day Low | $4.06 | EPS | $ | |||
| Volume | 439,239 | |||||
